Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial Infarction.

[1]  宮本 和享.  Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction (審査報告) , 2018 .

[2]  D. Srivastava,et al.  Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming , 2017, Circulation.

[3]  Malina J. Ivey,et al.  Defining the Cardiac Fibroblast. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Deepak Srivastava,et al.  In Vivo Cellular Reprogramming: The Next Generation , 2016, Cell.

[5]  B. Aronow,et al.  Genetic lineage tracing defines myofibroblast origin and function in the injured heart , 2016, Nature Communications.

[6]  Y. Maehara,et al.  Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101 , 2016, Scientific Reports.

[7]  Greg G. Wang,et al.  Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. , 2016, Cell stem cell.

[8]  N. Rosenthal,et al.  Revisiting Cardiac Cellular Composition. , 2016, Circulation research.

[9]  T. Furukawa,et al.  Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions , 2015, Stem cell reports.

[10]  C. Yin,et al.  In vivo cardiac reprogramming using an optimal single polycistronic construct. , 2015, Cardiovascular research.

[11]  Kenneth L. Jones,et al.  High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling , 2015, Nature Communications.

[12]  S. Yamanaka,et al.  Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. , 2015, Circulation research.

[13]  E. Finch,et al.  MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. , 2015, Circulation research.

[14]  M. Ieda,et al.  Stoichiometry of transcription factors is critical for cardiac reprogramming. , 2015, Circulation research.

[15]  N. Bursac,et al.  Stoichiometry of Gata4, Mef2c, and Tbx5 Influences the Efficiency and Quality of Induced Cardiac Myocyte Reprogramming , 2015, Circulation research.

[16]  村岡 直人.  MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures , 2015 .

[17]  E. Olson,et al.  Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors , 2014, Development.

[18]  S. Heymans,et al.  Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure , 2013, Nature Cell Biology.

[19]  Shinsuke Yuasa,et al.  Induction of human cardiomyocyte-like cells from fibroblasts by defined factors , 2013, Proceedings of the National Academy of Sciences.

[20]  D. Srivastava,et al.  Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro , 2013, Nature Protocols.

[21]  J Michael DiMaio,et al.  Making steady progress on direct cardiac reprogramming toward clinical application. , 2013, Circulation research.

[22]  KoheiInagawa,et al.  Induction of Cardiomyocyte-Like Cells in Infarct Hearts by Gene Transfer of Gata4, Mef2c, and Tbx5 , 2012 .

[23]  M. Nakanishi,et al.  Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine , 2012, Current gene therapy.

[24]  D. Srivastava,et al.  Critical factors for cardiac reprogramming. , 2012, Circulation research.

[25]  David Milan,et al.  Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5 , 2012, Circulation research.

[26]  E. Finch,et al.  MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes , 2012, Circulation research.

[27]  Xiaoxia Qi,et al.  Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.

[28]  Li Qian,et al.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.

[29]  S. Baek,et al.  Efficient inducible Cre‐mediated recombination in Tcf21cell lineages in the heart and kidney , 2011, Genesis.

[30]  Naoki Nishishita,et al.  Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors , 2011, Proceedings of the National Academy of Sciences.

[31]  Shinsuke Yuasa,et al.  Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. , 2010, Cell stem cell.

[32]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[33]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[34]  M. Hasegawa,et al.  Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques. , 2008, Vaccine.

[35]  A. M. Wright,et al.  Sendai virus-mediated CFTR gene transfer to the airway epithelium , 2007, Gene Therapy.

[36]  D. Geddes,et al.  Efficient gene transfer to airway epithelium using recombinant Sendai virus , 2000, Nature Biotechnology.

[37]  T. Hirata,et al.  A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression , 2000, Journal of Virology.